Regular Article
Phenylpropanolamine Potentiation of Acetaminophen-Induced Hepatotoxicity: Evidence for a Glutathione-Dependent Mechanism

https://doi.org/10.1006/taap.1993.1021Get rights and content

Abstract

Pretreatment of male ICR mice with the adrenergic agonist phenylpropanolamine (200 mg/kg, ip) resulted in a marked potentiation of hepatotoxicity produced by acetaminophen (400 mg/kg, ip). Enhanced liver necrosis with phenylpropanolamine pretreatment was evident both by measurement of serum aminotransferase activity and by histopathologic examination. Several lines of experimental evidence suggest this interaction is a result of the hepatic glutathione depression produced by a-adrenergic compounds, which adds to the glutathione depression caused by toxic, or nearly toxic, doses of acetaminophen. First, the potentiation of acetaminophen hepatotoxicity was time-dependent, being observed only when phenyipropanolamine was administered as a 3-hr pretreatment and not when given 1 hr before, with, or 3 hr after acetaminophen. The 3-hr interval between phenyipropanolamine and acetaminophen doses corresponds to the characteristic lag period required for α-adrenergic agents (including phenylpropanolamine) to produce significant and maximal effects on hepatic glutathione content. Second, dose-response relationships for phenylpropanolamine and acetaminophen were such that increased toxicity was observed only when the interaction was sufficient to lower hepatic glutathione concentrations below a level regarded as critical in preventing acetaminophen-induced hepatotoxicity. Third, when animals were pretreated with two nonadrenergic depletors of hepatic glutathione, diethylmaleate (125 mg/kg, ip) or the glutathione synthesis inhibitor buthionine sulfoximine (222 mg/kg, ip), at doses producing glutathione depletion approximating that observed with the adrenergic agents, acetaminophen hepatotoxicity was potentiated to the same extent. From these observations it is postulated that a variety of adrenergic compounds known to deplete hepatic glutathione by a moderate 30-50% may potentiate the hepatotoxicity of acetaminophen and possibly other hepatotoxic compounds for which glutathione conjugation is an important detoxification pathway.

References (0)

Cited by (30)

  • Comedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™

    2015, Regulatory Toxicology and Pharmacology
    Citation Excerpt :

    As carbamazepine induces several cytochrome P450s, it could enhance hepatotoxicity through this mechanism. Other compounds, including sympathetic stimulants, deplete glutathione (James et al., 1993) and inhibit liver repair mechanisms (Oben et al., 2003) thus increasing susceptibility. Carboxamides, pyrazinamide, and isoniazid are also known to induce epigenetic modifications (i.e., hypo-methylation and/or histone acetylation); decreased histone acetylation with isoniazid administration impairs liver regeneration after injury (Poirier and Wise, 2003; Murata et al., 2007).

  • Lysosome vacuolation disrupts the completion of autophagy during norephedrine exposure in SH-SY5Y human neuroblastoma cells

    2013, Brain Research
    Citation Excerpt :

    However, Nor is still available as a component of pharmaceutical products, dietary supplements and illegal drugs in many countries. Nor-induced cytotoxicity, which includes myocardial necrosis, hepatocytic necrosis, and injury to erythrocyte membranes, has been documented (Pentel et al., 1987; James et al., 1993; Suwalsky et al., 2011). However, despite the extensive information now available regarding Nor toxicity, detailed reports of the molecular mechanisms underlying this, particularly in neuronal cells, are scarce.

  • Co-medications That Modulate Liver Injury and Repair Influence Clinical Outcome of Acetaminophen-Associated Liver Injury

    2009, Clinical Gastroenterology and Hepatology
    Citation Excerpt :

    Further studies are needed to determine whether HGF may effectively enhance liver regeneration in older subjects. Sympathetic stimulants are known to enhance liver injury in the APAP animal model, partially via depletion of glutathione.22 Also, they inhibit hepatic regeneration through the inhibition of oval cell proliferation via adrenoreceptors.16,25

  • Protection against paracetamol-induced hepatic injury by prazosin pre-treatment in CD-1 mice

    2005, Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
  • Hepatotoxicity of androstenedione in pregnant rats

    2005, Food and Chemical Toxicology
    Citation Excerpt :

    Differences between the treated and control parameters with p ⩽ 0.05 were considered statistically significant. Hepatic ALT, AST, LDH, GSH, GST, P450, lipid peroxidation and DNA damage are commonly used as biomarkers of hepatotoxicity (Griffin et al., 1996; Hasegawa et al., 1995; James et al., 1993; Parola et al., 1996; Shen et al., 1994; Ushakova et al., 1996; Videla et al., 1995). The ALT and AST activities in serum are commonly used as clinical liver function tests.

View all citing articles on Scopus
View full text